Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Tetraphase Pharmaceu (TTPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 58,582
  • Shares Outstanding, K 53,745
  • Annual Sales, $ 18,900 K
  • Annual Income, $ -72,160 K
  • 60-Month Beta 3.00
  • Price/Sales 3.21
  • Price/Cash Flow N/A
  • Price/Book 0.76

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.39
  • Number of Estimates 4
  • High Estimate -0.28
  • Low Estimate -0.45
  • Prior Year -0.42
  • Growth Rate Est. (year over year) +7.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.02 +6.86%
on 04/18/19
1.37 -20.44%
on 04/01/19
-0.14 (-11.38%)
since 03/22/19
3-Month
1.02 +6.86%
on 04/18/19
1.45 -24.83%
on 03/18/19
-0.05 (-4.39%)
since 01/24/19
52-Week
1.01 +7.92%
on 12/31/18
4.49 -75.72%
on 06/15/18
-2.01 (-64.84%)
since 04/24/18

Most Recent Stories

More News
New Research: Key Drivers of Growth for Quintana Energy Services, ProQR Therapeutics N.V, Tetraphase Pharmaceuticals, Biomerica, Heat Biologics, and Bellerophon Therapeutics -- Factors of Influence, Major Initiatives and Sustained Production

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Quintana Energy Services Inc. (NYSE:QES),...

HTBX : 1.12 (-5.08%)
BMRA : 2.42 (+0.84%)
PRQR : 11.47 (-1.80%)
BLPH : 0.63 (-3.62%)
QES : 4.81 (+4.57%)
TTPH : 1.09 (-3.54%)
Tetraphase Pharmaceuticals to Present Data at the 29th European Congress of Clinical Microbiology and Infectious Diseases

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel tetracyclines to treat serious and life-threatening conditions,...

TTPH : 1.09 (-3.54%)
Robbins Arroyo LLP: Tetraphase Pharmaceuticals, Inc. (TTPH) Accused of Misleading Shareholders

Shareholder rights law firm Robbins Arroyo LLP reminds shareholders that purchasers of Tetraphase Pharmaceuticals, Inc. (NasdaqGS: TTPH) filed a class action complaint against the...

TTPH : 1.09 (-3.54%)
Tetraphase Pharmaceuticals Presents Preclinical Data on TP-2846, a Novel Drug Candidate for Acute Myeloid Leukemia

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel tetracyclines to treat serious and life-threatening conditions,...

TTPH : 1.09 (-3.54%)
Tetraphase Pharmaceuticals to Present at Upcoming Investor Conferences

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel tetracyclines to treat serious and life-threatening conditions,...

TTPH : 1.09 (-3.54%)
Tetraphase: 4Q Earnings Snapshot

WATERTOWN, Mass. (AP) _ Tetraphase Pharmaceuticals Inc. (TTPH) on Thursday reported a loss of $21.5 million in its fourth quarter.

TTPH : 1.09 (-3.54%)
Tetraphase Pharmaceuticals Reports Fourth Quarter and Full-Year 2018 Financial Results and Highlights Achievements and Key 2019 Milestones

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel tetracyclines to treat serious and life-threatening conditions,...

TTPH : 1.09 (-3.54%)
Tetraphase Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 14, 2019 / Tetraphase Pharmaceuticals, Inc. (NASDAQ: ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on March 14, 2019, 2018...

TTPH : 1.09 (-3.54%)
Tetraphase Pharmaceuticals to Host Fourth Quarter and Full-Year 2018 Financial Results Conference Call

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel tetracyclines to treat serious and life-threatening conditions,...

TTPH : 1.09 (-3.54%)
SmarTrend Watching for Potential Pullback in Shares of Tetraphase Pharm After 4.03% Gain

Tetraphase Pharm (NASDAQ:TTPH) traded in a range yesterday that spanned from a low of $1.20 to a high of $1.29. Yesterday, the shares gained 4.0%, which took the trading range above the 3-day high of...

TTPH : 1.09 (-3.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade TTPH with:

Business Summary

Tetraphase Pharmaceuticals, Inc. is a life science company engaged in developing and commercializing tetracycline based drugs to treat drug-resistant infectious diseases, inflammation, and cancer. Its principal products include eravacycline, an intravenous and oral antibiotic for the treatment of multi-drug...

See More

Key Turning Points

2nd Resistance Point 1.16
1st Resistance Point 1.12
Last Price 1.09
1st Support Level 1.05
2nd Support Level 1.02

See More

52-Week High 4.49
Fibonacci 61.8% 3.16
Fibonacci 50% 2.75
Fibonacci 38.2% 2.34
Last Price 1.09
52-Week Low 1.01

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar